PALADIN Consortium

The PALADIN Playbook provides practical insights and shares proven collaboration strategies in developing impactful collaborations between PAGs and Industry stakeholders. View the Playbook here to get started: https://lnkd.in/exhwG_SH

To enhance the success of PAG-industry collaborations, we highly recommend leveraging PALADIN resources like the Playbook. These tools offer essential guidance on best practices for collaboration, ensuring that efforts are effective and aligned with patient needs. The document highlighted below Industry and PAG Study Considerations for Effective Clinical Trial Execution encompass strategies and guidelines to optimize collaboration between patient advocacy groups (PAGs) and the industry, ensuring clinical trials are effectively communicated. Visit the downloads section of the Playbook to learn more: https://lnkd.in/e27GeH2M

Excited to share how work with PALADIN is creating impactful tools for seamless stakeholder collaboration and benefiting patients? See what Josee Pelletier, MBA had to say about our shared commitment to collaboration.

To maximize the effectiveness of PAG-industry collaborations, we strongly encourage utilizing PALADIN resources such as the roadmap infographic. Much like other PALADIN tools, the roadmap provides valuable guidance on best practices for collaboration, ensuring efforts are productive and aligned with patient needs. The infographic visually summarizes key strategies and benefits of PAG-industry collaboration, highlighting the importance of patient-centric approaches and culturally appropriate communication. Visit the downloads section of the Playbook to learn more: https://lnkd.in/exhwG_SH

Successful collaboration between industry and patient groups can, and should, span the product lifecycle. The PALADIN Skills and Training Workstream has developed a helpful tool that depicts the many opportunities and value of this interaction from early Research (Pre-discovery) through Commercialization (Approval and beyond). Please visit, the playbook here to learn more: https://lnkd.in/e27GeH2M

We are thrilled to announce that we will be speaking at the #DIAGlobal conference in San Diego, CA, on June 18th. Join us to learn about PALADIN’s mission to transform the pace of medicines development through collaboration between patient advocacy groups and pharmaceutical companies. We will also provide an update on the PALADIN Consortium. Victoria DiBiaso Ken Getz Hollie Schmidt #DIAGlobal #DIAConference2024

The PALADIN Skills and Training Workstream has developed training materials to help Patient Advocacy Groups (PAGs) and the industry understand each other better and create effective working relationships. Visit the link below to learn about the 5 key things patient advocacy groups should know about biopharmaceutical companies: https://lnkd.in/eAgj5Vu2

The PALADIN Consortium was created to deliver the needed tools and resources for effective collaboration. The PALADIN Skills and Training Workstream has produced training materials that can be used to help PAGs and industry better understand each other and develop appropriate ways of working. Please visit the link below to check out 5 Things for Biopharmaceutical to Know about PAGs: https://lnkd.in/eAgj5Vu2

We would like to honor the important work of the PALADIN member organization Accelerated Cure Project for Multiple Sclerosis who are working to improve the health outcomes of those with Multiple Sclerosis. Sara Loud Hollie Schmidt

Collaboration between PAGs and the industry is crucial for ensuring new treatments align with patient priorities. See what PALADIN member Bruce Miller had to say about effective interaction and collaboration.